John A Belperio MD
Critical Care Medicine, Pleural Disease
Professor, Medicine, UCLA School of Medicine
Join to View Full Profile
200 Medical Plaza, Suite 365-BLos Angeles, CA 90095
Phone+1 310-825-8061
Fax+1 310-825-8061
Dr. Belperio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
University of MarylandResidency, Internal Medicine, 1994 - 1997
Lewis Katz School of Medicine at Temple UniversityClass of 1994
Certifications & Licensure
CA State Medical License 2000 - 2027
MI State Medical License 1997 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
Clinical Trials
- Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation Start of enrollment: 2006 Jan 01
- Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan Start of enrollment: 2007 Oct 01
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- The Natural History of Chronic Lung Allograft Dysfunction in Single and Bilateral Orthotopic Lung Transplant Recipients.Shahrzad M Lari, Juhyun Kim, Jin Zhou, David M Sayah, Ariss Der Hovanessian
Transplantation. 2026-04-20 - Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.Brian C Keller, Sean Agbor-Enoh, Michael B Keller, Sravanthi Nandavaram, Adriana Zeevi
The Journal of Heart and Lung Transplantation. 2026-04-15 - 1 citationsReduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk.Jeeyon G Rim, Jeremy M Weber, Megan L Neely, Nicholas O'Grady, Francine L Kelly
The European Respiratory Journal. 2026-04-01
Press Mentions
UCLA Receives $20 Million from Saul and Joyce Brandman Foundation for New Lung Health CenterMarch 6th, 2025- Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health ConsequencesJanuary 16th, 2025
- Theravance Biopharma : Announces Top-Line Results from Phase 2 Study of Nezulcitinib in Patients Hospitalized with Acute Lung Injury Due to COVID-19 (Form 8-K)June 21st, 2021
Grant Support
- The UCLA Pulmonary and Critical Care Medicine Scientist Training Program (PCCM-STP)UNIVERSITY OF CALIFORNIA LOS ANGELES2003–2030
- Lung Transplant Clinical Trial Network (LT-CTN)DUKE UNIVERSITY2025–2028
- Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary FibrosisUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- The Role Of Chemokines During Lung Allograft DysfunctionNational Heart, Lung, And Blood Institute2005–2009
- Chemokine Biology In Bronchiolitis Obliterans SyndromeNational Heart, Lung, And Blood Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
